相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis
Jun-O Jin et al.
CELL DEATH AND DIFFERENTIATION (2021)
Strategies To Design Selective Histone Deacetylase Inhibitors
Jelena Melesina et al.
CHEMMEDCHEM (2021)
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke et al.
CANCERS (2021)
The PROTACtable genome
Melanie Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points
Alesa Bricelj et al.
FRONTIERS IN CHEMISTRY (2021)
E3 ligase RCHY1 negatively regulates HDAC2
Mina Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Role of HDACs in normal and malignant hematopoiesis
Pan Wang et al.
MOLECULAR CANCER (2020)
The functions and regulation of Smurfs in cancers
Lin Fu et al.
SEMINARS IN CANCER BIOLOGY (2020)
Siah2 control of T-regulatory cells limits anti-tumor immunity
Marzia Scortegagna et al.
NATURE COMMUNICATIONS (2020)
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
Yuan Fang et al.
ACTA PHARMACEUTICA SINICA B (2020)
SIAH2-mediated and organ-specific restriction of HO-1 expression by a dual mechanism
Shashipavan Chillappagari et al.
SCIENTIFIC REPORTS (2020)
The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2
Jung Ok Lee et al.
FEBS JOURNAL (2020)
The RING Domain of RING Finger 12 Efficiently Builds Degradative Ubiquitin Chains
A. J. Middleton et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Ka Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
Helge M. Magnussen et al.
NATURE COMMUNICATIONS (2020)
Roles of the HUWE1 ubiquitin ligase in nervous system development, function and disease
Andrew C. Giles et al.
NEURAL DEVELOPMENT (2020)
Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases
Kundlik Gadhave et al.
BIOMOLECULES (2020)
Proteolysis targeting chimeras (PROTACs) for epigenetics research
Anja Vogelmann et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
The Post-translational Modifications of Smurf2 in TGF-β Signaling
Yangjinming Bai et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Molecular Mechanisms of the Teratogenic Effects of Thalidomide
Tomoko Asatsuma-Okumura et al.
PHARMACEUTICALS (2020)
Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
Daniel A. Rodrigues et al.
MEDICINAL RESEARCH REVIEWS (2020)
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma
Lisa J. Crawford et al.
ONCOGENE (2020)
Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
Yudibeth Sixto-Lopez et al.
SCIENTIFIC REPORTS (2020)
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Joshua P. Smalley et al.
MOLECULES (2020)
A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 Degradation and Synergizes with Volasertib to Suppress Lung Cancer
Lifeng Li et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
The Role of HDACs and HDACi in Cartilage and Osteoarthritis
He Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells
Christine Surka et al.
BLOOD (2020)
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
Fangyuan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
Donglu Wu et al.
FRONTIERS IN ONCOLOGY (2020)
Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC
Jiangying Cao et al.
MOLECULES (2020)
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs
Yufeng Xiao et al.
CHEMICAL COMMUNICATIONS (2020)
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Joshua P. Smalley et al.
CHEMICAL COMMUNICATIONS (2020)
Novel immunomodulatory drugs and neo-substrates
Shaobing Gao et al.
BIOMARKER RESEARCH (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder
Suzanna G. M. Frints et al.
MOLECULAR PSYCHIATRY (2019)
E3 ubiquitin ligases in B-cell malignancies
Jaewoo Choi et al.
CELLULAR IMMUNOLOGY (2019)
A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells
Lukasz Skalniak et al.
FEBS JOURNAL (2019)
Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes
Joerg Kallen et al.
CHEMMEDCHEM (2019)
Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages
Fangyuan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
HECT E3 Ligases: A Tale With Multiple Facets
Janine Weber et al.
FRONTIERS IN PHYSIOLOGY (2019)
KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders
Xinchen Teng et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
Hao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
IMiDs New and Old
Samuel Yamshon et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Recent advances in class IIa histone deacetylases research
Yodita Asfaha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
PROTACs- a game-changing technology
Markella Konstantinidou et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
The ubiquitin ligase adaptor SPOP in cancer
Matthew J. Cuneo et al.
FEBS JOURNAL (2019)
The emerging role for Cullin 4 family of E3 ligases in tumorigenesis
Ji Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Rlim/Rnf12, Rex1, and X Chromosome Inactivation
Feng Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Targeted Synthesis of Complex Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2-p53 Inhibitors
Andreas Gollner et al.
CHEMMEDCHEM (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
Developing potent PROTACs tools for selective degradation of HDAC6 protein
Zixuan An et al.
PROTEIN & CELL (2019)
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies
Drew W. Rasco et al.
CLINICAL CANCER RESEARCH (2019)
Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation
Richard S. Marshall et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Bivalent Ligands for Protein Degradation in Drug Discovery
Marcel Scheepstra et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Plasticity in designing PROTACs for selective and potent degradation of HDAC6
Haiyan Yang et al.
CHEMICAL COMMUNICATIONS (2019)
Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyI)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyppyrrolidine-2-carboxamide (VH298)
Pedro Soares et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Ka Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Regulating the human HECT E3 ligases
Jasper Sluimer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Small molecules as tools to study the chemical epigenetics of lysine acetylation
Matthias Schiedel et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2018)
Structural basis of thalidomide enantiomer binding to cereblon
Tomoyuki Mori et al.
SCIENTIFIC REPORTS (2018)
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53
Dong Yang et al.
THERANOSTICS (2018)
RNF12 X-Linked Intellectual Disability Mutations Disrupt E3 Ligase Activity and Neural Differentiation
Francisco Bustos et al.
CELL REPORTS (2018)
Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
Li Yang et al.
PROTEIN & CELL (2018)
Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
Emil Bulatov et al.
FRONTIERS IN PHARMACOLOGY (2018)
Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin-proteasome pathway
Hong Chen et al.
BIOORGANIC CHEMISTRY (2018)
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53-MDM2 Inhibitor HDM201
Sebastien Jeay et al.
CANCER RESEARCH (2018)
Smurfs in Protein Homeostasis, Signaling, and Cancer
Praveen Koganti et al.
FRONTIERS IN ONCOLOGY (2018)
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
Quinlan L. Sievers et al.
SCIENCE (2018)
Ubiquitination by HUWE1 in tumorigenesis and beyond
Shih-Han Kao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation
Kevin B. Myant et al.
EMBO MOLECULAR MEDICINE (2017)
Drugging the undruggabl: targeting challenging E3 ligases for personalized medicine
Carles Galdeano
FUTURE MEDICINAL CHEMISTRY (2017)
The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways
Lisa Dwane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Koji Nomura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex
Teresa A. F. Cardote et al.
STRUCTURE (2017)
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
Koji Nomura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6
Yuyong Tan et al.
ONCOTARGET (2017)
A conformational switch regulates the ubiquitin ligase HUWE1
Bodo Sander et al.
ELIFE (2017)
Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation
Qinglin Shi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear
Qi Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation
Philipp Ottis et al.
ACS CHEMICAL BIOLOGY (2017)
A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction
Ewa Surmiak et al.
ACS CHEMICAL BIOLOGY (2016)
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo et al.
CANCER CELL (2016)
SnapShot: Types of Ubiquitin Ligases
Francesca Ester Morreale et al.
CELL (2016)
The recognition of ubiquitinated proteins by the proteasome
Guinevere L. Grice et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles
Melissa R. Marzahn et al.
EMBO JOURNAL (2016)
The BTB domains of the potassium channel tetramerization domain proteins prevalently assume pentameric states
Giovanni Smaldone et al.
FEBS LETTERS (2016)
Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 Interaction
Andreas Gollner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structural Insights into KCTD Protein Assembly and Cullin3 Recognition
Alan X. Ji et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
Cereblon in health and disease
Hyoung Kyu Kim et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
The-N-End Rule: The Beginning Determines the End
Mohamed Eldeeb et al.
PROTEIN AND PEPTIDE LETTERS (2016)
Cullin-RING ligases in regulation of autophagy
Danrui Cui et al.
CELL DIVISION (2016)
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors
Stephane L. Bogen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification
Duk-Hwa Kwon et al.
NATURE COMMUNICATIONS (2016)
Atlas on substrate recognition subunits of CRL2 E3 ligases
Siwei Wang et al.
ONCOTARGET (2016)
Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases
Qiuyang Zheng et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation
Rui Gao et al.
PLOS ONE (2016)
CHFR negatively regulates SIRT1 activity upon oxidative stress
Myungjin Kim et al.
SCIENTIFIC REPORTS (2016)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
Biao Ma et al.
NATURE CELL BIOLOGY (2015)
Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins
Giovanni Smaldone et al.
PLOS ONE (2015)
RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Meredith B. Metzger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Tobias Wagner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
H Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
Stefanie Peter et al.
EMBO MOLECULAR MEDICINE (2014)
HDAC4 integrates PTH and sympathetic signaling in osteoblasts
Arnaud Obri et al.
JOURNAL OF CELL BIOLOGY (2014)
Structure-Guided Design and Optimization of Small Molecules Targeting the Protein Protein Interaction between the von Hippel- Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities
Carles Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P. Chamberlain et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?
David M. Dias et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
KCTD11 Tumor Suppressor Gene Expression Is Reduced in Prostate Adenocarcinoma
Francesca Zazzeroni et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP
Laura K. van Geersdaele et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Smurf E3 ubiquitin ligases at the cross roads of oncogenesis and tumor suppression
Diana David et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2013)
The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover
M. Bohgaki et al.
CELL DEATH AND DIFFERENTIATION (2013)
Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
Yong-Sam Jung et al.
FEBS LETTERS (2012)
Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover
Stephan Lange et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
RNF12 Controls Embryonic Stem Cell Fate and Morphogenesis in Zebrafish Embryos by Targeting Smad7 for Degradation
Long Zhang et al.
MOLECULAR CELL (2012)
Adaptor Protein Self-Assembly Drives the Control of a Cullin-RING Ubiquitin Ligase
Wesley J. Errington et al.
STRUCTURE (2012)
Molecular organization of the cullin E3 ligase adaptor KCTD11
Stefania Correale et al.
BIOCHIMIE (2011)
Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2
Jing Zhang et al.
GENES & DEVELOPMENT (2011)
Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins
Kimberly Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR
Liang Zhou et al.
PLOS ONE (2011)
Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
Vinod Pant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The cullin protein family
Antonio Sarikas et al.
GENOME BIOLOGY (2011)
Identification and Characterization of KCASH2 and KCASH3, 2 Novel Cullin3 Adaptors Suppressing Histone Deacetylase and Hedgehog Activity in Medulloblastoma
Enrico De Smaele et al.
NEOPLASIA (2011)
The Ski protein negatively regulates Siah2-mediated HDAC3 degradation
Hong-Ling Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Structural Basis of Poly(ADP-ribose) Recognition by the Multizinc Binding Domain of Checkpoint with Forkhead-associated and RING Domains (CHFR)
Jasmeen Oberoi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors
M. Michela Mancarelli et al.
MOLECULAR CANCER (2010)
Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
Gianluca Canettieri et al.
NATURE CELL BIOLOGY (2010)
Armadillo Motifs Involved in Vesicular Transport
Harald Striegl et al.
PLOS ONE (2010)
Molecular Basis for the Association of Human E4B U Box Ubiquitin Ligase with E2-Conjugating Enzymes UbcH5c and Ubc4
Robert C. Benirschke et al.
STRUCTURE (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers
Mai Shimada et al.
CANCER SCIENCE (2009)
Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin Ligases
Min Zhuang et al.
MOLECULAR CELL (2009)
Chfr is linked to tumour metastasis through the downregulation of HDAC1
Young Mi Oh et al.
NATURE CELL BIOLOGY (2009)
UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1α turnover
Gabriela Alexandru et al.
CELL (2008)
FHA-RING ubiquitin ligases in cell division cycle control
L. Brooks et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis
Yutaka Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein
Xudong Zhao et al.
NATURE CELL BIOLOGY (2008)
Molecular basis of Pirh2-mediated p53 ubiquitylation
Yi Sheng et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Targeted degradation of the aryl hydrocarbon receptor by the PROTAC approach: A useful chemical genetic tool
Hyosung Lee et al.
CHEMBIOCHEM (2007)
Autoinhibition of the HECT-Type ubiquitin ligase smurf2 through its c2 domain
Silke Wiesner et al.
CELL (2007)
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity
Masha V. Poyurovsky et al.
EMBO JOURNAL (2007)
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX
Stjepan Uldrijan et al.
EMBO JOURNAL (2007)
FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions
Trijnie Dijkhuizen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer
Ian R. Logan et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2
P. Andrew Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain
AA Ogunjimi et al.
MOLECULAR CELL (2005)
Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis
Q Zhong et al.
CELL (2005)
Chfr is required for tumor suppression and Aurora A regulation
XC Yu et al.
NATURE GENETICS (2005)
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
L Gaughan et al.
NUCLEIC ACIDS RESEARCH (2005)
Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain
S Jo et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Hypoxia-inducible factor (HIF-1)α:: its protein stability and biological functions
JW Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
RENKCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
L Di Marcotullio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protein degradation and protection against misfolded or damaged proteins
AL Goldberg
NATURE (2003)
Critical role for a central part of Mdm2 in the ubiquitylation of p53
E Meulmeester et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
OH Krämer et al.
EMBO JOURNAL (2003)
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation
RP Leng et al.
CELL (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate
ES Stavridi et al.
STRUCTURE (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
DM Scolnick et al.
NATURE (2000)
分享论文
